Schizophrenia.com
Biogen’s stock jumps 30% after FDA staff says it has enough data to support approving Alzheimer’s drug
Lounge
everhopeful
November 4, 2020, 4:06pm
1
1 Like
system
Closed
November 18, 2020, 4:06pm
2
This topic was automatically closed 14 days after the last reply. New replies are no longer allowed.
Related topics
Topic
Replies
Views
Activity
FDA approves Biogen's Alzheimer's drug, the first new therapy for the disease in nearly 2 decades
Lounge
9
286
July 1, 2021
The FDA Is Reviewing Biogen's 'Breakthrough' Alzheimer's Treatment
Lounge
2
162
August 24, 2020
Biotech stocks plunge after FDA makes it easier for public to search for drug side effects
Medications
0
636
September 29, 2017
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
Lounge
1
12
August 9, 2024
Karuna's stock jumps 42% after sharing promising Phase 3 data for its schizophrenia drug
News
30
925
August 13, 2022